Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitor-associated Myocarditis”

5 trials

Showing 5 of 5 results

Not applicableUnknownNCT04294771
What this trial is testing

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

Who this might be right for
MyocarditisCardiomyopathiesHeart Diseases+3 more
Groupe Hospitalier Pitie-Salpetriere 500,000
Not applicableStudy completedNCT03387540
What this trial is testing

Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions

Who this might be right for
MyocarditisCardiac Complication
Groupe Hospitalier Pitie-Salpetriere 104
Not applicableNot Yet RecruitingNCT07280429
What this trial is testing

ICIAM Rehabilitation Program Study: A Randomized Controlled Trial

Who this might be right for
Immune Checkpoint Inhibitors Related Myocarditis
China-Japan Friendship Hospital 60
Not applicableLooking for participantsNCT07633587
What this trial is testing

ATROPOS: Survival Analysis of ICI-associated Myocarditis

Who this might be right for
Immune Checkpoint Inhibitor-associated Myocarditis
Groupe Hospitalier Pitie-Salpetriere 1,500
Large-scale testing (Phase 3)Looking for participantsNCT05335928
What this trial is testing

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Who this might be right for
Myocarditis AcuteCancer
Massachusetts General Hospital 390

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation